Latest Sustainability In It News

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.

N1 Holdings reports a profitable FY2025 with strategic expansion into Australia's largest aggregator panel and launches AI-driven credit tools to enhance SME lending operations.

Epsilon Healthcare has completed a $6.7 million sale and leaseback of its Southport manufacturing site, significantly reducing debt and securing long-term operational stability.

Metals X has updated its Renison Tin Operation mineral resources to 20.8 million tonnes at 1.40% tin, incorporating new drilling data and the Ringrose Prospect. The update signals ongoing resource growth amid operational challenges.

Zoono Group Limited reports strong progress in its shelf-life extension technology with 45 active trials worldwide and anticipates UK revenue by Q2 FY26 following successful supermarket partnerships.

Hydrocarbon Dynamics Limited reported ongoing sales and expanded trials of its HCD Multi-Flow product worldwide, alongside plans for a fully underwritten rights issue to bolster its financial position.

Gullewa Limited reported a solid cash balance of A$8.1 million at the end of June 2025, supported by positive operating cash flow despite ongoing investment in exploration and corporate activities.

Minbos Resources has secured key financing and made significant construction strides on its Angolan phosphate fertilizer plant, while rolling out promising new fertilizer blends to support local agriculture.

EQ Resources has locked in a US$7.5 million royalty funding agreement with Oaktree Management, aimed at expanding and enhancing its Barruecopardo tungsten project in Spain. This deal strengthens the company’s balance sheet and supports critical capital projects to increase production capacity.

Aurum Resources has reported impressive high-grade gold assay results from its extensive diamond drilling at the Boundiali Gold Project in Côte d'Ivoire, reinforcing the project's potential and underpinning ambitious exploration and development targets for 2025.

Prescient Therapeutics has raised $6.8 million through a Share Purchase Plan to fund the Phase 2 development of its novel cancer therapy PTX-100, while launching a discounted placement to sophisticated investors.

ActivEX Limited reports a maiden gold resource of 310,000 ounces at its Gilberton project and broadens its rare earth element exploration with new tenement applications in Queensland.